Prognosis of early XXXX .

@entity1 @entity5 @entity189 @entity3 @entity356
PURPOSE: Little is known about the clinicopathological features of early @entity356 ( @entity356 ). The purpose of this study was to compare the clinicopathological features and prognosis between @entity1 with early @entity356 and those with early nonmucinous @entity356 (NMGC). METHODS: We reviewed the records of 2,732 @entity1 diagnosed with @entity356 who were treated surgically. There were 14 @entity1 (0.5%) with early @entity356 and 958 with early NMGC. RESULTS: Early @entity356 @entity1 had a higher prevalence of elevated type (71.4%) compared with early NMGC @entity1 (29.5%). More early @entity356 @entity1 had @entity189 , compared with early NMGC @entity1 (78.6% vs. 64.1%). The overall 5-year survival of the @entity1 with early @entity356 was 97.2% as compared with 92.7% for the @entity1 with early NMGC (P < 0.01). The statistically significant prognostic parameters influencing the 5-year survival rate according to Cox's proportional hazard regression model were: age (risk ratio, 2.22; 95% confidence interval [CI], 1.62-3.04; P < 0.01); sex (risk ratio, 1.97; 95% CI, 1.42-2.73; P < 0.01); and lymph node @entity3 (risk ratio, 1.88; 95% CI, 1.28-2.77; P < 0.01). CONCLUSION: @entity1 with early @entity356 had a better prognosis than those with early NMGC. Mucinous histology itself appears not to be an independent prognostic factor. Therefore, early detection is important for improving the prognosis for @entity1 with @entity356 regardless of @entity5 histology.
